Miscellaneous antifungal medications

Last updated: November 01, 2022

Miscellaneous antifungal medications

CONA CM

CONA CM

Anemia: Clinical
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Myeloproliferative disorders: Pathology review
Myeloproliferative neoplasms: Clinical
Leukemias: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Platelet disorders: Pathology review
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombosis syndromes (hypercoagulability): Pathology review
Thrombophilia: Clinical
Peripheral vascular disease: Clinical
Venous thromboembolism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombolytics
Antiplatelet medications
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Blood products and transfusion: Clinical
Vaccinations: Clinical
Pneumonia: Clinical
Abscesses
Infective endocarditis: Clinical
Skin and soft tissue infections: Clinical
Septic arthritis
Osteomyelitis
Fever of unknown origin: Clinical
Diarrhea: Clinical
Gastroenteritis
Clostridium difficile (Pseudomembranous colitis)
Urinary tract infections: Clinical
Sexually transmitted infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Salmonellosis
Shigella
Vibrio cholerae (Cholera)
Brucella
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Mycobacterium leprae
Treponema pallidum (Syphilis)
Leptospira
Upper respiratory tract infection
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
HIV (AIDS)
Herpes simplex virus
Varicella zoster virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Cytomegalovirus
Coccidioidomycosis and paracoccidioidomycosis
Aspergillus fumigatus
Mucormycosis
Plasmodium species (Malaria)
Antimalarials
Leishmania
Trypanosoma cruzi (Chagas disease)
Toxoplasma gondii (Toxoplasmosis)
Ascaris lumbricoides
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Enterobius vermicularis (Pinworm)
Anthelmintic medications
Bites and stings: Clinical
Cytomegalovirus infection after transplant (NORD)
Mechanisms of antibiotic resistance
Streptococcus pyogenes (Group A Strep)
Miscellaneous antifungal medications
Candida
Staphylococcus aureus
Pediatric infectious rashes: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart blocks: Pathology review
Pulseless electrical activity
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Cardiomyopathies: Clinical
Endocarditis
Myocarditis
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Valvular heart disease: Clinical
Pericarditis and pericardial effusion
Cardiac tamponade
Dressler syndrome
Pericardial disease: Clinical
Myocardial infarction
Coronary artery disease: Clinical
Renal artery stenosis
Hypertension: Clinical
Aortic aneurysms and dissections: Clinical
Pulmonary hypertension
Peripheral artery disease
Chronic venous insufficiency
Leg ulcers: Clinical
Congenital heart defects: Clinical
Lymphedema
Syncope: Clinical
Tuberculosis: Pathology review
Asthma: Clinical
Diffuse parenchymal lung disease: Clinical
Bronchiectasis
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer: Clinical
Pleural effusion: Clinical
Anatomy clinical correlates: Pleura and lungs
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Sleep apnea
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Pneumothorax: Clinical
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Kidney stones: Clinical
Esophageal disorders: Clinical
Esophageal surgical conditions: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Viral hepatitis: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Alcohol-associated liver disease
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Rheumatoid arthritis: Clinical
Joint pain: Clinical
Scleroderma: Pathology review
Sjogren syndrome: Clinical
Seronegative arthritis: Clinical
Vasculitis: Clinical
Inflammatory myopathies: Clinical
Sarcoidosis
Gout and pseudogout: Pathology review
Antigout medications
Fibromyalgia
Hypopituitarism: Clinical
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Congenital adrenal hyperplasia: Clinical
MEN syndromes: Clinical
Cushing syndrome: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Diabetes mellitus: Clinical
Hypercholesterolemia: Clinical
Osteoporosis
Hemochromatosis
Seizures: Clinical
Cerebral vascular disease: Pathology review
Stroke: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Alzheimer disease
Parkinson disease
Hypokinetic movement disorders: Clinical
Hyperkinetic movement disorders: Clinical
Trigeminal neuralgia
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Muscle weakness: Clinical
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Shock: Clinical
Disorders of consciousness: Clinical
Subarachnoid hemorrhage

Transcript

Watch video only

Antifungal agents are a class of medications used to treat mycoses, or fungal infections.

Mycoses can be superficial, meaning they are localized on the skin, or develop into systemic infections in immunodeficient patients.

Antifungals work either through fungistatic action, meaning that they inhibit fungal growth, or through fungicidal action, meaning they kill the fungi.

Now, antifungals include the azole family and a novel class of medications, echinocandins; but there are also many other antifungals with similar or different mechanisms that we’ll talk about in this video.

Okay, most fungal cells have a tough outer cell wall and an inner cell membrane.

The cell membrane is mostly made of phospholipids with some sterol or modified steroid molecules mixed in.

Humans have cholesterol, while fungi have ergosterol. Both sterol molecules help keep the cell membrane stable at a wide range of temperatures.

Now, the precursor to both molecules is lanosterol.

The precursor of lanosterol is squalene.

The conversion of squalene to lanosterol is catalyzed by an enzyme called squalene epoxidase.

Fungi have a cytochrome p450 enzyme called fourteen-alpha-demethylase in their mitochondria and endoplasmic reticulums, which converts lanosterol to ergosterol.

Without ergosterol, the structure of the cell membrane will be disrupted.

This will cause membrane-bound proteins, like ion channels, to stop working properly.

The membrane also becomes fragile, which eventually leads to inhibition of fungal growth.

Okay, let’s start with polyenes, which are naturally-derived antifungal antibiotics that alter cell membrane permeability.

They include amphotericin, also called amphotericin B, and nystatin.

Polyenes have both hydrophilic, meaning they love water, and lipophilic, meaning they love fats, characteristics.

They bind to ergosterol, and the hydrophilic core causes the formation of artificial pores in the cell membrane, thereby creating a leaky membrane.

This causes significant changes in ion balance including the loss of intracellular potassium.

Depending on their concentration, polyenes are either fungistatic or fungicidal.

Now, amphotericin B is one of the most important medications for the treatment of systemic mycoses. It’s used to fight systemic infections caused by Aspergillus, Blastomyces, Candida albicans, Cryptococcus, Histoplasma, and Mucor, either alone or in combination with other drugs.

However, nowadays several azoles and echinocandins are proving to be just as effective in specific systemic mycoses as amphotericin B is, with less risk of toxicity.

Amphotericin B is also used in the treatment of visceral Leishmaniasis, caused by protozoan parasites of the genus Leishmania, that presents with fever, weight loss, fatigue, anemia, and substantial swelling of the liver and spleen.

It’s usually given by slow intravenous infusion, as it is poorly absorbed by the gastrointestinal tract.

In fungal meningitis intrathecal administration, meaning injection into the spinal canal, or into the subarachnoid space, has been used, since the drug is widely distributed to all tissues except the central nervous system, or CNS, when administered intravenously.

It can also be administered locally in the treatment of mycotic corneal ulcers and keratitis.

Amphotericin is mainly eliminated via hepatic metabolism, while a small fraction is excreted through the kidneys.

Alright, now common side effects are infusion-related and include fever, chills, muscle spasms, vomiting, headache, and in more severely affected individuals, hypotension and anaphylactoid reactions.

The most serious side effect is renal toxicity which is dose dependent and can be decreased with hydration.

Anemia may also occur due to reduction of erythropoietin production from the kidneys.

Amphotericin decreases glomerular filtration rate in the majority of the patients, which improves after treatment stops, and causes renal tubular acidosis with loss of magnesium and potassium.

This can lead to hypokalemia and hypomagnesemia which often requires subsequent potassium and magnesium supplementation.

The electrolyte imbalance can cause arrythmias.

Other side effects include impaired hepatic function and intrathecal administration may cause seizures and neurotoxicity.

Next, nystatin is an antifungal agent that is only effective in the treatment of Candida infections of the skin, mucous membranes and gastrointestinal tract.

It’s used either topically for superficial infections or orally to fight gastrointestinal fungi in patients with impaired defense mechanisms.

Side effects for the oral form include gastrointestinal disturbances like nausea, abdominal pain, vomiting, and diarrhea.

Both the oral and the topical form can cause hypersensitivity reactions such as Stevens-Johnson syndrome, which is a dangerous immune-mediated condition that affects the skin and mucous membranes such as the mouth and genitals, and also rashes, itching, and burning.

Moving on to terbinafine, which is a synthetic antifungal antibiotic that alters cell membrane permeability.

Key Takeaways

There are a few different types of antifungal medications, but they all work in similar ways. Most of them work by disrupting the formation of the fungal cell wall, which eventually kills the fungus. Some common antifungal medications include azoles (such as fluconazole and itraconazole), polyenes (such as amphotericin B and nystatin), and echinocandins (such as caspofungin and anidulafungin).

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "The antifungal pipeline: a reality check" Nature Reviews Drug Discovery (2017)
  5. "Onychomycosis" Journal of the American Academy of Dermatology (2019)
  6. "New Antifungal Agents and New Formulations Against Dermatophytes" Mycopathologia (2016)